nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00708	0.119	CbGeAlD
Anisotropine Methylbromide—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00644	0.109	CbGeAlD
Anisotropine Methylbromide—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00599	0.101	CbGeAlD
Anisotropine Methylbromide—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00577	0.0973	CbGeAlD
Anisotropine Methylbromide—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00545	0.0919	CbGeAlD
Anisotropine Methylbromide—CHRM3—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.0046	0.00489	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00435	0.00462	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00409	0.00435	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00406	0.00431	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00398	0.00423	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00394	0.00418	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00384	0.0648	CbGeAlD
Anisotropine Methylbromide—CHRM3—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.0038	0.00404	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.0037	0.0624	CbGeAlD
Anisotropine Methylbromide—CHRM3—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00362	0.00385	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00355	0.00378	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—nervous system—attention deficit hyperactivity disorder	0.0035	0.059	CbGeAlD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0034	0.00362	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00337	0.0568	CbGeAlD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00334	0.00355	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00333	0.00354	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0033	0.0035	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00327	0.00348	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00327	0.00348	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00326	0.00347	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00326	0.00347	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00325	0.00345	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00324	0.00344	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00323	0.00343	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00323	0.00343	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00321	0.00341	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00313	0.0528	CbGeAlD
Anisotropine Methylbromide—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00301	0.0508	CbGeAlD
Anisotropine Methylbromide—CHRM2—brain—attention deficit hyperactivity disorder	0.00294	0.0496	CbGeAlD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00293	0.00311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00286	0.00304	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00285	0.00303	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00282	0.003	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00281	0.00299	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0028	0.00298	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00279	0.00297	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00277	0.00294	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00272	0.00289	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00272	0.00289	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—brain—attention deficit hyperactivity disorder	0.00267	0.0451	CbGeAlD
Anisotropine Methylbromide—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00259	0.00276	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00257	0.00273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00241	0.00256	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—brain—attention deficit hyperactivity disorder	0.00239	0.0404	CbGeAlD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00227	0.00241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00226	0.0024	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00225	0.00239	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00225	0.00239	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00224	0.00238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00218	0.00232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00218	0.00232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00217	0.00231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00215	0.00229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00213	0.00227	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00213	0.00226	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00212	0.00225	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00211	0.00224	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00211	0.00224	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00205	0.00218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00198	0.00211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00198	0.0021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00198	0.0021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00197	0.0021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00196	0.00208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00194	0.00207	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00194	0.00206	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00192	0.00204	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0019	0.00202	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00187	0.00198	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00184	0.00196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00184	0.00196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00184	0.00195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00184	0.00195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00183	0.00195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00182	0.00193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00181	0.00193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00178	0.0019	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00178	0.00189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00176	0.00187	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00175	0.00186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00175	0.00186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00173	0.00184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00173	0.00184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00173	0.00184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00172	0.00183	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00171	0.00182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00169	0.0018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00168	0.00178	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00167	0.00177	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00167	0.00177	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00166	0.00177	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00165	0.00175	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00161	0.00172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00161	0.00171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00159	0.00169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00158	0.00168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00157	0.00167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00156	0.00166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00153	0.00163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00152	0.00162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00151	0.0016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0015	0.0016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0015	0.00159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00148	0.00158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00148	0.00158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00148	0.00157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00148	0.00157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00147	0.00157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00147	0.00156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00146	0.00155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00138	0.00147	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00138	0.00147	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00137	0.00145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00131	0.00139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0013	0.00139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.00131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.0013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00122	0.00129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00121	0.00128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0012	0.00128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0012	0.00128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0012	0.00127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00119	0.00127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00119	0.00126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00116	0.00124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00116	0.00123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00115	0.00122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00113	0.0012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00113	0.0012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.0012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00113	0.0012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00113	0.0012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00112	0.00119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0011	0.00116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00109	0.00116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00108	0.00115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00105	0.00112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00105	0.00112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000985	0.00105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000982	0.00104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000972	0.00103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000969	0.00103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000965	0.00103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000956	0.00102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000884	0.00094	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000836	0.000889	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000833	0.000886	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000825	0.000877	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000787	0.000837	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000769	0.000817	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000766	0.000815	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000759	0.000807	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000759	0.000807	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000757	0.000805	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00075	0.000797	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000738	0.000784	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000735	0.000782	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000731	0.000777	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000731	0.000777	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000729	0.000774	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000728	0.000774	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000721	0.000767	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000679	0.000722	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000677	0.00072	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000671	0.000713	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000664	0.000706	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000662	0.000703	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000661	0.000702	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000658	0.0007	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000658	0.0007	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000656	0.000697	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000655	0.000696	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000652	0.000693	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00065	0.000691	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000647	0.000688	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000647	0.000688	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000645	0.000686	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000645	0.000685	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000639	0.000679	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000639	0.000679	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000638	0.000679	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000637	0.000677	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000635	0.000675	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000633	0.000672	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000631	0.00067	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000626	0.000666	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000617	0.000656	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000615	0.000654	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000609	0.000647	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000598	0.000635	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000596	0.000633	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000595	0.000633	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000593	0.000631	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00059	0.000627	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000587	0.000624	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000587	0.000624	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000585	0.000622	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00058	0.000617	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00058	0.000616	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000578	0.000615	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000573	0.000609	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000544	0.000578	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000544	0.000578	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00054	0.000574	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000539	0.000573	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000535	0.000568	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000533	0.000567	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000497	0.000528	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000449	0.000477	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000447	0.000475	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000443	0.000471	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000435	0.000462	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000417	0.000443	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000415	0.000442	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000414	0.00044	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000411	0.000437	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000392	0.000417	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000391	0.000415	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000387	0.000411	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000378	0.000402	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000377	0.000401	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000374	0.000397	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000364	0.000387	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000363	0.000386	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00036	0.000382	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000353	0.000375	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000352	0.000374	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000348	0.00037	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000347	0.000369	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000346	0.000368	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000343	0.000364	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.000364	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000342	0.000363	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000338	0.00036	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000329	0.00035	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000327	0.000348	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000319	0.000339	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000318	0.000338	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000315	0.000335	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000224	0.000238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000223	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000221	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000141	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000118	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000118	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000117	0.000124	CbGpPWpGaD
